IDEXX Laboratories Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	180.07	288.27	453.93	112.55	144.45
Cash & Short-Term Investments	180.07	288.27	453.93	112.55	144.45
Cash Growth	-37.53%	-36.50%	303.33%	-22.09%	-62.38%
Accounts Receivable	628.21	534.33	512.56	442.47	406.12
Other Receivables	64.99	26.99	16.97	48.43	19.46
Receivables	693.19	561.32	529.53	490.9	425.58
Inventory	377.76	381.88	380.28	367.82	269.03
Prepaid Expenses	57.9	58.63	48.37	41.74	42
Other Current Assets	104.91	109.81	83.14	88.46	74.59
Total Current Assets	1,414	1,400	1,495	1,101	955.66
Property, Plant & Equipment	870.61	829.25	817.68	768.09	692.77
Long-Term Investments	31.76	31	30.25	30.25	5.25
Goodwill	414	405.1	365.96	361.8	359.35
Other Intangible Assets	109.84	111.68	84.5	97.67	99.04
Long-Term Accounts Receivable	236.91	185.51	167.96	148.97	122.16
Long-Term Deferred Tax Assets	27.87	125.63	107.36	55.22	24.78
Long-Term Deferred Charges	-	-	-	-	122.41
Other Long-Term Assets	245.94	205.38	190.96	183.29	55.8
Total Assets	3,351	3,293	3,260	2,747	2,437
Accounts Payable	110.41	114.21	110.64	110.22	116.14
Accrued Expenses	414.41	418.33	372.36	364.69	395.77
Short-Term Debt	398	250	250	579	73.5
Current Portion of Long-Term Debt	75	167.79	75	74.98	75
Current Portion of Leases	27.07	21.54	19.8	20.43	19.93
Current Income Taxes Payable	88.67	62.25	86.55	48.55	42.61
Current Unearned Revenue	35.26	33.8	37.2	37.94	40.03
Other Current Liabilities	-	-	-	-	0.6
Total Current Liabilities	1,149	1,068	951.55	1,236	763.58
Long-Term Debt	375.29	449.79	622.88	694.39	775.21
Long-Term Leases	101.15	97.84	99.67	101.24	87.38
Long-Term Unearned Revenue	32.18	26.94	28.53	30.86	41.17
Long-Term Deferred Tax Liabilities	31.87	11.31	7.24	8.15	8.94
Other Long-Term Liabilities	56.08	44.34	65.53	67.59	70.94
Total Liabilities	1,745	1,698	1,775	2,138	1,747
Common Stock	10.84	10.78	10.75	10.72	10.69
Additional Paid-In Capital	1,827	1,674	1,570	1,463	1,377
Retained Earnings	6,392	5,332	4,445	3,600	2,920
Treasury Stock	-6,561	-5,334	-4,475	-4,392	-3,571
Comprehensive Income & Other	-62.75	-87.76	-65.68	-72.61	-47.77
Total Common Equity	1,605	1,595	1,485	608.74	689.99
Shareholders' Equity	1,605	1,595	1,485	608.74	689.99
Total Liabilities & Equity	3,351	3,293	3,260	2,747	2,437
Total Debt	976.51	986.95	1,067	1,470	1,031
Net Cash (Debt)	-796.44	-698.68	-613.42	-1,357	-886.56
Net Cash Per Share	-9.83	-8.39	-7.30	-16.05	-10.24
Filing Date Shares Outstanding	79.62	81.33	83.09	82.9	84.25
Total Common Shares Outstanding	79.71	81.6	83.03	82.89	84.56
Working Capital	265.01	331.98	543.71	-134.33	192.08
Book Value Per Share	20.14	19.55	17.88	7.34	8.16
Tangible Book Value	1,082	1,079	1,034	149.27	231.61
Tangible Book Value Per Share	13.57	13.22	12.45	1.80	2.74
Land	24.64	23.99	22.4	22.22	22.64
Buildings	462.39	446.16	432.04	356.05	329.09
Machinery	991.76	891	837.15	772.56	728.74
Construction In Progress	68.98	67.14	79.06	97.31	62.34
Leasehold Improvements	125.3	119.84	116.35	107.25	93.25

Source: S&P Global Market Intelligence. Standard template. Financial Sources.